The DOI matches its Crossref record; 293 of the 293 references it cites were found in a registry or an index.
Matrix metalloproteinases participation in the metastatic process and their diagnostic and therapeutic applications in cancer
Open accessAbstract
Matrix metalloproteinases (MMPs) participate from the initial phases of cancer onset to the settlement of a metastatic niche in a second organ. Their role in cancer progression is related to their involvement in the extracellular matrix (ECM) degradation and in the regulation and processing of adhesion and cytoskeletal proteins, growth factors, chemokines and cytokines. MMPs participation in cancer progression makes them an attractive target for cancer therapy. MMPs have also been used for theranostic purposes in the detection of primary tumor and metastatic tissue in which a particular MMP is overexpressed, to follow up on therapy responses, and in the activation of cancer cytotoxic pro-drugs as part of nano-delivery-systems that increase drug concentration in a specific tumor target. Herein, we review MMPs molecular characteristics, their synthesis regulation and enzymatic activity, their participation in the metastatic process, and how their functions have been used to improve cancer treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
3 retracted
Items 201–293 of 293
Mitropoulou, T. N., Tzanakakis, G. N., Kletsas, D., Kalofonos, H. P., & Karamanos, N. K. (2003) · International Journal of Cancer · doi:10.1002/ijc.10941 · Cited by 71
Matrilysin (matrix metalloproteinase-7) selects for apoptosis-resistant mammary cells in vivo.
Vargo-Gogola, T. C., Fingleton, B., Crawford, H. C., & Matrisian, L. M. (2002) · PubMed · Cited by 71
Lu, C. S., Lee, J. J., Komaki, R. U., Herbst, R. S., Feng, L., Evans, W. K., Choy, H., Desjardins, P., Esparaz, B. T., Truong, M. T., et al. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq179 · Cited by 71
Arresten, a Collagen-Derived Angiogenesis Inhibitor, Suppresses Invasion of Squamous Cell Carcinoma
Aikio, M., Alahuhta, I., Nurmenniemi, S., Suojanen, J., Palovuori, R., Teppo, S., Sorsa, T. A., López-Otín, C., Pihlajaniemi, T. A., Salo, T. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051044 · Cited by 69
Paupert, J., Sounni, N. E., & Noël, A. (2011) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.04.002 · Cited by 69
Probes for Non-invasive Matrix Metalloproteinase-targeted Imaging with PET and SPECT
Matusiak, N., van Waarde, A., Bischoff, R., Oltenfreiter, R., van Wiele, C., Dierckx, R. A. J. O., & Elsinga, P. H. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319250011 · Cited by 69
Yang, C., Zhu, L., Xu, X., Ning, T., Ye, J., & Liu, L. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-171 · Cited by 69
Tetrastatin, the NC1 Domain of the α4(IV) Collagen Chain: A Novel Potent Anti-Tumor Matrikine
Brassart‐Pasco, S., Sénéchal, K., Thévenard, J., Ramont, L., Devy, J., Stefano, L. D., Dupont-Deshorgue, A., Brézillon, S., Feru, J., Jazeron, J.-F., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029587 · Cited by 66
Villeneuve, J., Block, A. K., Bousse‐Kerdilès, M. L., Lepreux, S., Nurden, P., Ripoche, J., & Nurden, A. T. (2009) · Experimental Hematology · doi:10.1016/j.exphem.2009.03.009 · Cited by 66
Karagiannis, E. D., & Popel, A. S. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.12.231 · Cited by 66
Homeostatic Signaling by Cell–Cell Junctions and Its Dysregulation during Cancer Progression
Yu, Y., & Elble, R. C. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5020026 · Cited by 66
Ali, M. A., Fan, X., & Schulz, R. (2011) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2012.03.008 · Cited by 65
Hypoxia-inducible factor 1α regulates lung adenocarcinoma cell invasion
Shyu, K., Hsu, F., Wang, M. J., Wang, B.-W., & Lin, S. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.01.013 · Cited by 65
Matrix metalloproteinases in stem cell mobilization
Klein, G., Schmal, O., & Aicher, W. K. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.01.011 · Cited by 65
Tabouret, É., Boudouresque, F., Barrié, M., Matta, M., Boucard, C., Loundou, A., Carpentier, A., Sanson, M., Métellus, P., Figarella‐Branger, D., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not226 · Cited by 65
Lopes-Bastos, B., Jiang, W. G., & Cai, J. (2016) · PubMed · Cited by 65
Stromelysin‐3 suppresses tumor cell apoptosis in a murine model*
Wu, E., Mari, B. P., Wang, F., Anderson, I. C., Sunday, M. E., & Shipp, M. A. (2001) · Journal of Cellular Biochemistry · doi:10.1002/jcb.1181 · Cited by 64
Targeting a Single Function of the Multifunctional Matrix Metalloprotease MT1-MMP
Ingvarsen, S., Porse, A., Erpicum, C., Maertens, L., Jürgensen, H. J., Madsen, D. H., Melander, M. C., Gårdsvoll, H., Høyer‐Hansen, G., Noël, A., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.447169 · Cited by 63
John, H., Radtke, K., Ständker, L., & Forssmann, W. (2004) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2004.10.013 · Cited by 63
Nishida, C., Kusubata, K., Tashiro, Y., Gritli, I., Sato, A., Ohki, M., Morita, Y., Nagano, M., Sakamoto, T., Koshikawa, N., et al. (2012) · Blood · doi:10.1182/blood-2011-11-390849 · Cited by 62
Savinov, A. Y., Remacle, A. G., Golubkov, V. S., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3592 · Cited by 62
Zoledronic acid use in cancer patients: More than just supportive care?
Coleman, R. E., Cook, R. J., Hirsh, V., Major, P. P., & Lipton, A. (2010) · Cancer · doi:10.1002/cncr.25529 · Cited by 61
Chou, C.-H., Teng, C.-M., Tzen, K., Chang, Y.-C., Jh, C., & Cheng, J. C. (2011) · Oncogene · doi:10.1038/onc.2011.240 · Cited by 61
Ip, Y. C., Cheung, S., & Fan, S. T. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20270 · Cited by 61
Jing, S., Wang, Y.-D., Kuroda, M., Su, J.-W., Sun, G.-G., Liu, Q., Cheng, Y.-J., & Yang, C.-R. (2012) · PubMed · doi:10.18926/amo/48964 · Cited by 61
Chan, K. C., Ko, J. M. Y., Lung, H. L., et al. (2010) · International Journal of Cancer · doi:10.1002/ijc.25855 · Cited by 60
Chabottaux, V., Ricaud, S., Host, L., Blacher, S., Paye, A., Thiry, M., Garofalakis, A., Pestourie, C., Gombert, K., Bruyére, F., et al. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00764.x · Cited by 60
Miyoshi, A., Kitajima, Y., Ide, T., Ohtaka, K., Nagasawa, H., Uto, Y., Hori, H., & Miyazaki, K. (2006) · International Journal of Oncology · doi:10.3892/ijo.29.6.1533 · Cited by 59
Loreto, C., Leonardi, R. M., Musumeci, G., Pannone, G., & Castorina, S. (2013) · European Journal of Histochemistry · doi:10.4081/ejh.2013.e12 · Cited by 59
Shirure, V. S., Liu, T., Delgadillo, L. F., Cuckler, C. M., Tees, D. F. J., Benencia, F., Goetz, D. J., & Burdick, M. M. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00094.2014 · Cited by 59
Koskimaki, J. E., Karagiannis, E. D., Tang, B. C., Hammers, H. J., Watkins, D. N., Пили, Р., & Popel, A. S. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-29 · Cited by 58
Nagase, H., Itoh, Y., & BINNER, S. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb24744.x · Cited by 57
Li, W., Savinov, A. Y., Rozanov, D. V., Golubkov, V. S., Hedayat, H., Postnova, T. I., Golubkova, N. V., Linli, Y., Krajewski, S., & Strongin, A. Y. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-3019 · Cited by 57
Matrix Metalloproteinases and Platelet Function
Gresele, P., Falcinelli, E., Sebastiano, M., & Momi, S. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.01.002 · Cited by 57
Li, R., Wu, W., Liu, Q., Wu, P., Li, X., Zhu, Z., Yang, M., Qian, X., Ding, Y., Yu, L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069643 · Cited by 56
Mastenbroek, T. G., Feijge, M. A. H., Kremers, R., van den Bosch, M. T. J., Swieringa, F., Groef, L. D., Moons, L., Bennett, C., Ghevaert, C., Johnson, J. L., et al. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306153 · Cited by 56
Xu, T., Jing, C., Shi, Y., Miao, R., Peng, L., Kong, S., Ma, Y., & Li, L. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2538 · Cited by 55
Lin, J.-L., Wang, M. J., Lee, D., Liang, C.-C., & Lin, S. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.06.033 · Cited by 55
Lebel, R., ̧bska, B. J., Therriault, H., Cournoyer, M., McIntyre, J. O., Escher, E., Neugebauer, W. A., Paquette, B., & Lepage, M. (2008) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21741 · Cited by 54
MT1-MMP promotes vascular smooth muscle dedifferentiation through LRP1 processing
Lehti, K., Rose, N. F., Valavaara, S., Weiss, S. J., & Keski-Oja, J. (2009) · Journal of Cell Science · doi:10.1242/jcs.035279 · Cited by 52
Hida (2010) · International Journal of Oncology · doi:10.3892/ijo_00000622 · Cited by 50
Blavier, L., Lazaryev, A., Shi, X.-H., Dorey, F. J., Shackleford, G. M., & DeClerck, Y. A. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.2.12193 · Cited by 49
Osteopontin-Enhanced Hepatic Metastasis of Colorectal Cancer Cells
Huang, J., Pan, C., Hu, H., Zheng, S. S., & Ding, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047901 · Cited by 49
PECAM-1 promotes β-catenin accumulation and stimulates endothelial cell proliferation
Biswas, P., Canosa, S., Schoenfeld, J. D., Schoenfeld, D. A., Tucker, A., & Madri, J. A. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00313-9 · Cited by 48
İşlekel, H., Oktay, G., Terzi, C., Canda, A. E., Füzün, M., & Küpelioğlu, A. (2006) · Cell Biochemistry and Function · doi:10.1002/cbf.1325 · Cited by 47
Xu, M., & Wang, Y. (2013) · Oncology Reports · doi:10.3892/or.2013.2548 · Cited by 47
Revisiting the dynamic cancer stem cell model: Importance of tumour edges
Hernández-Camarero, P., Jiménez, G., López‐Ruiz, E., Barungi, S., Marchal, J. A., & Perán, M. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.08.004 · Cited by 46
Aldonytė, R., Mark, B., Edward, B. Z., Patel, J. M., & Jianliang, Z. (2009) · Experimental Lung Research · doi:10.1080/01902140802406059 · Cited by 45
Schütz, A., Röser, K., Klitzsch, J., Lieder, F., Aberger, F., Gruber, W., Mueller, K. M., Pupyshev, A. B., Moriggl, R., & Friedrich, K. (2015) · Translational Oncology · doi:10.1016/j.tranon.2015.02.002 · Cited by 45
Ou‐Yang, F., Hou, M., Yang, S., Huang, S.-C., & Lee, W. (2009) · PubMed · Cited by 45
Transcriptional upregulation of MT2‐MMP in response to hypoxia is promoted by HIF‐1α in cancer cells
Zhu, S., Zhou, Y., Wang, L., Zhang, J., Wu, H.-Q., Xiong, J., Zhang, J., Tian, Y., Wang, C., & Wu, H. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20678 · Cited by 44
Wong, M., Sidik, S. M., Mahmud, R., & Stanslas, J. (2013) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12083 · Cited by 43
Wu, Q.-W., Yang, Q., Huang, Y., She, H.-Q., Liang, J., Yang, Q., & Zhang, Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097804 · Cited by 43
Partridge, J. J., Madsen, M. A., Ardi, V. C., Papagiannakopoulos, T. Y., Kupriyanova, T. A., Quigley, J. P., & Deryugina, E. I. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705993200 · Cited by 43
Shen, Z., Yao, C., Wang, Z., Yue, L., Fang, Z., Yao, H., Feng, L., Zhao, H., Sun, Y.-J., Bian, X., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2016.56 · Cited by 43
Kocemba‐Pilarczyk, K. A., van Andel, H., de Haan-Kramer, A., Mahtouk, K., Versteeg, R., Kersten, M. J., Spaargaren, M., & Pals, S. T. (2013) · Leukemia · doi:10.1038/leu.2013.76 · Cited by 42
Tabouret, É., Bertucci, F., Pierga, J., Petit, T., Lévy, C., Ferrero, J.-M., Campone, M., Gligorov, J., Lerebours, F., Roche, H. H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7612 · Cited by 42
Yeghiazaryan, M., Żybura-Broda, K., Cabaj, A. M., Włodarczyk, J., Sławińska, U., Rylski, M., & Wilczynski, G. M. (2012) · Histochemistry and Cell Biology · doi:10.1007/s00418-012-0940-5 · Cited by 40
Æ-941 (Neovastat®): a novel multifunctional antiangiogenic compound
Gingras, D., Batist, G., & Béliveau, R. (2001) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.1.3.341 · Cited by 39
Yamamoto, A., Kasamatsu, A., Ishige, S., Koike, K., Saito, K., Kouzu, Y., Koike, H., Sakamoto, Y., Ogawara, K., Shiiba, M., et al. (2012) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-012-1356-2 · Cited by 39
Joo, N. E., Watanabe, T., Chen, C., Chekenya, M., Stallcup, W. B., & Kapila, Y. L. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.22 · Cited by 37
Fukuda, H., Mochizuki, S., Abe, H., Okano, H. J., Hara‐Miyauchi, C., Okano, H., Yamaguchi, N., Nakayama, M., D'Armiento, J. M., & Okada, Y. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.431 · Cited by 36
Sheep, wolf, or werewolf: Cancer stem cells and the epithelial-to-mesenchymal transition
Chang, J. T., & Mani, S. A. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.03.004 · Cited by 34
Intracellular MMP‐2 Activity in Skeletal Muscle Is Associated With Type II Fibers
Hadler‐Olsen, E., Solli, A. I., Hafstad, A. D., Winberg, J., & Uhlin‐Hansen, L. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24694 · Cited by 33
SRF is a nuclear repressor of Smad3-mediated TGF-β signaling
Lee, H.-J., Yun, C.-H., Lim, S., Kim, B.-C., Baik, K. G., Kim, J.-M., Kim, W. H., & Kim, S. J. (2006) · Oncogene · doi:10.1038/sj.onc.1209774 · Cited by 33
Delany, A. M., & CANALIS, E. M. (2001) · Endocrinology · doi:10.1210/endo.142.4.8072 · Cited by 32
Meisel, J. E., & Chang, M. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.04.011 · Cited by 32
Miyata, S., Nakatani, Y., Hayashi, N., & Nakashima, T. (2005) · Brain Research · doi:10.1016/j.brainres.2005.07.027 · Cited by 30
Tumor talk: understanding the conversation between the tumor and its microenvironment
Whipple, C. A. (2015) · Cancer Cell & Microenvironment · doi:10.14800/ccm.773 · Cited by 30
The origins of vacularization in tumors
Liu, J., Huang, J., Yao, W.-Y., Ben, Q.-W., Chen, D.-F., He, X.-Y., Li, L., & Yuan, Y.-Z. (2012) · Frontiers in bioscience · doi:10.2741/4071 · Cited by 29
Angiostatin inhibits endothelial MMP-2 and MMP-14 expression: A hypoxia specific mechanism of action
Radziwon‐Balicka, A., Ramer, C., de la Rosa, C. M., Zielnik, B., & Jurasz, P. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.11.003 · Cited by 28
Yu, X., Wei, F., Yu, J., Zhao, H., Jia, L., Ye, Y., Du, R., Ren, X., & Li, H. (2015) · Cancer Genetics · doi:10.1016/j.cancergen.2015.01.006 · Cited by 28
Çoşkun, U., Yamaç, D., Gülbahar, Ö., Sancak, B., Karaman, N., & Özkan, S. A. (2007) · PubMed · Cited by 28
Human neutrophil collagenase expression is C/EBP-dependent during myeloid development
Khanna‐Gupta, A., Zibello, T., Idone, V. J., Sun, H., Lekstrom-Himes, J. A., & Berliner, N. (2005) · Experimental Hematology · doi:10.1016/j.exphem.2004.09.009 · Cited by 26
MiR-129 regulates MMP9 to control metastasis of non-small cell lung cancer
Li, J., Wang, H., Ke, H., & Ni, S. (2015) · Tumor Biology · doi:10.1007/s13277-015-3247-z · Cited by 25
Peyri, N., Bérard, M., Fauvel-Lafève, F., Trochon-Joseph, V., Arbeille, B., Lu, H., Legrand, C., & Crépin, M. (2009) · PubMed · Cited by 25
Brasse, D., Mathelin, C., Leroux, K., Chenard, M., Blaise, S. A., Stoll, I., Tomasetto, C., & Rio, M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25309 · Cited by 24
Endostatin and anastellin inhibit distinct aspects of the angiogenic process
Neskey, D. M., Ambesi, A., Pumiglia, K. M., & McKeown‐Longo, P. J. (2008) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-27-61 · Cited by 20
Khamis, Z. I., Iczkowski, K. A., Man, Y., Bou-Dargham, M. J., & Sang, Q. A. (2015) · Journal of Cancer · doi:10.7150/jca.13067 · Cited by 20
Zhang, S., Liu, Y., Wang, Z., Liu, J., Gu, Z., Xu, Q., & Su, L. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6303 · Cited by 19
Endostatin specifically targets both tumor blood vessels and lymphatic vessels
Zhuo, W., Chen, Y., Song, X., & Luo, Y. (2011) · Frontiers of Medicine · doi:10.1007/s11684-011-0163-5 · Cited by 18
Vacek, T. P., Metreveli, N. S., Tyagi, N., Vacek, J. C., Pagni, S., & Tyagi, S. C. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.12.039 · Cited by 17
An extracellular proteasome releases endostatin from human collagen XVIII
Reiss-Pistilli, M. L. V., Schuppan, D., Barroso, M. M. S., Assunção‐Miranda, I., Farias, S. L., Lery, L. M. S., Bauer, M. W., Juliano, L., Juliano, M. A., & Coelho‐Sampaio, T. (2016) · Angiogenesis · doi:10.1007/s10456-016-9533-6 · Cited by 17
Akslen, L. A., Straume, O., Geisler, S. B., Sørlie, T., Chi, J.-T., Aas, T., Børresen-Dale, A.-L., & Lønning, P. E. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.203 · Cited by 16
Dedes, P. G., Kanakis, I., Gialeli, C., Theocharis, A. D., Tsegenidis, T., Kletsas, D., Tzanakakis, G. N., & Karamanos, N. K. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.01.020 · Cited by 15
Hwang‐Bo, J., Park, J., Bae, M. G., & Chung, I. S. (2016) · Cancer Medicine · doi:10.1002/cam4.866 · Cited by 15
Azorin‐Vega, E. P., Solano‐Agama, C., & Mendoza‐Garrido, M. E. (2012) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2012.08.011 · Cited by 13
Regulatory effects of ΔFosB on proliferation and apoptosis of MCF-7 breast cancer cells
Li, H., Li, L., Zheng, H., Yao, X., & Zang, W. (2015) · Tumor Biology · doi:10.1007/s13277-015-4356-4 · Cited by 13
Cho, C., Kelsh, R., Ambesi, A., & McKeown‐Longo, P. J. (2015) · PubMed · Cited by 13
MMP13 Regulates Aggressiveness of Pediatric Multiple Myeloma Through VEGF-C
Xu, L., Sun, K., Xia, M., Li, X., & YanMing, L. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000430116 · Cited by 12
Matrix metalloproteinase‐1 contribution to sarcoma cell invasion
Garamszegi, N., Garamszegi, S. P., & Scully, S. P. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01402.x · Cited by 12
Validation of Different Systems for Tumstatin Expression and its in-vitro and iv-vivo Activities
Boosani, C. S., Verma, A. K., & Sudhakar, A. (2009) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.1000002 · Cited by 10
Caspase-9 activation and Apaf-1 cleavage by MMP-3
Kim, E., Shin, E.-J., Lee, J. A., Son, H. J., Choi, D. H., Han, J. M., & Hwang, O. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.09.124 · Cited by 10
Cited by
Bertocchi, A., Carloni, S., Ravenda, P. S., Bertalot, G., Spadoni, I., Lo Cascio, A., Gandini, S., Lizier, M., Braga, D., Asnicar, F., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.03.004 · Cited by 515
Matrix Metalloproteinases Shape the Tumor Microenvironment in Cancer Progression
Niland, S., Riscanevo, A. X., & Eble, J. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010146 · Cited by 503
Neophytou, C. M., Panagi, M., Stylianopoulos, T., & Papageorgis, P. (2021) · Cancers · doi:10.3390/cancers13092053 · Cited by 456
Myricetin: A review of the most recent research
Song, X., Tan, L., Wang, M., Ren, C., Guo, C., Yang, B., Ren, Y., Cao, Z., Li, Y., & Pei, J. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111017 · Cited by 378
Extracellular Matrix Alterations in Metastatic Processes
Paolillo, M., & Schinelli, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194947 · Cited by 377
Metadata
- Authors
- Gonzalez-Avila, G., Sommer, B., Mendoza-Posada, D. A., Ramos, C., Garcia-Hernandez, A. A., & Falfan-Valencia, R.
- Venue
- Critical Reviews in Oncology/Hematology
- Publisher
- Elsevier BV
- Published
- 2019-05
- Volume
- 137
- Pages
- 57-83
- ISSN
- 1040-8428 (ISSN-L)
- OpenAlex
- W2919016311
- Cited by
- 373
- References
- 293
- FWCI
- 13.27
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.